Natural Compounds as Broad-Spectrum Anti-viral Therapeutics: The Benefit for Human Health

Dear Colleagues,

The COVID-19 pandemic has brought the world to a standstill and highlighted the urgent need for effective therapeutics to combat viral infections. While significant progress has been made in developing vaccines and antiviral drugs, the emergence of new variants and the need for broad-spectrum therapeutics have become increasingly important. One promising area of research is the use of natural compounds as broad-spectrum antiviral therapeutics in order to contribute to human health.

Natural compounds, such as those found in plants, are rich sources of therapeutic agents utilized in both traditional and modern medicine for treating diseases and maintaining health. They have been used for centuries in traditional medicine for the prevention and treatment of viral infections.  Recent studies have shown that many natural compounds have potent antiviral activity against a wide range of viruses, including SARS-CoV-2. These compounds, such as phytochemicals and herbal remedies, have the potential to boost the immune system, reduce inflammation, and provide symptom relief.

This Special Issue focuses on the latest research on the use of natural compounds as broad-spectrum antiviral therapeutics and their benefits for human health. The articles in this Special Issue cover a wide range of topics, including in vitro and in vivo studies, clinical trials, and the final results of the effects of natural compounds in humans. The goal of this Special Issue is to provide a comprehensive overview of the current state of the field and to highlight the potential of natural compounds as a viable alternative or complementary treatment for viral infections and their relationship to their benefits in humans.

We hope that this Special Issue will inspire further research and the development of natural compounds as broad-spectrum antiviral therapeutics, ultimately leading to the discovery of new treatments for COVID-19 and other viral infections for the advancement of human health.

Prof. Dr. Jamal Mahajna
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.